Back to FIRST TRUST ADVISORS LP FIRST TRUST ADVISORS LP

HALOHALO
Showing 8 of 31 quarters

Position history for FIRST TRUST ADVISORS LPFIRST TRUST ADVISORS LP's holdings in HALOZYME THERAPEUTICS INC

FIRST TRUST ADVISORS LP holds 1.4M shares of HALO (HALOZYME THERAPEUTICS INC), worth $110.9M as of 2026-Q2. The position was decreased (-4.4% shares). HALO represents 0.1% of FIRST TRUST ADVISORS LP's portfolio.

Current Value

$110.9M

Current Shares

1.4M

Total Value Change

+$60.7M

Total Shares Change

+540,200

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.4M
-4.4%
$110.9M0.1%$78.27
0
2026-Q1
Increased
1.5M
+46.5%
$95.8M0.1%$69.40
41
2025-Q4
Increased
1M
+30.3%
$68.1M0.0%$67.70
37
2025-Q3
Increased
776,411
+1.4%
$56.9M0.0%$73.29
30
2025-Q2
Decreased
765,918
-4.7%
$39.8M0.0%$52.21
0
2025-Q1
Decreased
803,694
-6.5%
$51.3M0.0%$63.84
0
2024-Q4
Decreased
859,572
-2.0%
$41.1M0.0%$47.99
0
2024-Q3
Decreased
876,863
-14.6%
$50.2M0.0%$56.97
0

Other major holders of HALO: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used